Two Sigma Investments, LP Summit Therapeutics Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$2.55 - $5.07 $210,629 - $418,782
-82,600 Reduced 77.79%
23,579 $97,000
Q3 2023

Nov 14, 2023
SELL
$1.54 - $2.42 $116,732 - $183,436
-75,800 Reduced 41.65%
106,179 $198,000
Q2 2023

Aug 14, 2023
SELL
$1.32 - $2.81 $440,825 - $938,424
-333,959 Reduced 64.73%
181,979 $456,000
Q1 2023

May 15, 2023
BUY
$1.38 - $5.41 $317,038 - $1.24 Million
229,738 Added 80.27%
515,938 $902,000
Q4 2022

Feb 14, 2023
BUY
$0.68 - $5.31 $194,616 - $1.52 Million
286,200 New
286,200 $1.22 Million

Others Institutions Holding SMMT

# of Institutions
192
Shares Held
75.8M
Call Options Held
2.01M
Put Options Held
2.84M
View Full List

About Summit Therapeutics Inc.

SMMT Quotes by TradingView
  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.6B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email